<DOC>
	<DOCNO>NCT01932528</DOCNO>
	<brief_summary>To evaluate metabolism route extent elimination telotristat etiprate primary metabolite LX1033 .</brief_summary>
	<brief_title>An Open-label Study Evaluate Absorption , Metabolism , Excretion 14C-Telotristat Etiprate Males</brief_title>
	<detailed_description />
	<mesh_term>Malignant Carcinoid Syndrome</mesh_term>
	<mesh_term>Serotonin Syndrome</mesh_term>
	<criteria>Healthy male subject age 30 65 year age . Male subject partner must agree use adequate method contraception Historically able produce minimum 1 bowel movement every day day Female subject Use medication supplement within 5 day prior Dosing Radiation exposure exceed 5 millisieverts ( mSv ) last 12 month 10 mSv last 5 year Current smoker use cigarette within 90 day prior Screening History renal disease abnormal kidney function History hepatic disease Acute diarrhea constipation within 7 day dose Positive urine glucose Screening</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Absorption</keyword>
	<keyword>Metabolism</keyword>
	<keyword>Excretion</keyword>
</DOC>